Analyst firms · BofA Securities · OSCR

BofA Securities OSCR price target and rating history

Oscar Health Inc. (OSCR) · Health Care

BofA Securities rates Oscar Health Inc. (OSCR) Underperform with a $13.50 price target, as of its latest action on Nov 6, 2024. It has published 6 rating actions on OSCR since May 2022, including 2 upgrades and 4 downgrades. Across 7 firms with a OSCR price target in the last 12 months, the median target is $18.

Current rating
Underperform
Price target
$13.50
Median target, all firms
$18
Actions on OSCR
6

BofA Securities price target on OSCR

$21$13$4.502023202420252026
BofA Securities price target on OSCR, each point a stated target, May 2022 to November 2024.

Every BofA Securities rating on OSCR

How other firms rate OSCR

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BarclaysOverweight$35Jun 10, 2026
Wells FargoEqual Weight$20Jun 4, 2026
Wolfe ResearchPeer PerformMay 6, 2026
JefferiesHold$16Apr 20, 2026
Raymond JamesOutperform$18Feb 12, 2026
UBSNeutral$17Jan 9, 2026
StephensEqual-Weight$17Dec 11, 2025
Piper SandlerOverweight$25Nov 26, 2025

Questions about BofA Securities and OSCR

What is BofA Securities's price target for OSCR?
BofA Securities's latest stated price target for Oscar Health Inc. (OSCR) is $13.50, from its action on Nov 6, 2024.
What is BofA Securities's rating on OSCR?
BofA Securities rates OSCR Underperform, a bearish rating, as of Nov 6, 2024.
When did BofA Securities last change its view on OSCR?
On Nov 6, 2024, BofA Securities downgrades to Underperform from Neutral, price target $21 to $13.50.
How does BofA Securities's OSCR target compare with other analysts?
Across 7 firms with a OSCR price target in the last 12 months, the median target is $18.

More OSCR rating histories

All BofA Securities ratingsOSCR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.